A guide to complement biology, pathology and therapeutic opportunity

DC Mastellos, G Hajishengallis… - Nature Reviews …, 2024 - nature.com
Complement has long been considered a key innate immune effector system that mediates
host defence and tissue homeostasis. Yet, growing evidence has illuminated a broader …

Complement in the brain: contributions to neuroprotection, neuronal plasticity, and neuroinflammation

SS Bohlson, AJ Tenner - Annual Review of Immunology, 2023 - annualreviews.org
The complement system is an ancient collection of proteolytic cascades with well-described
roles in regulation of innate and adaptive immunity. With the convergence of a revolution in …

C3‐dependent effector functions of complement

A Zarantonello, M Revel, A Grunenwald… - Immunological …, 2023 - Wiley Online Library
C3 is the central effector molecule of the complement system, mediating its multiple
functions through different binding sites and their corresponding receptors. We will introduce …

Terminal complement pathway activation drives synaptic loss in Alzheimer's disease models

SM Carpanini, M Torvell, RJ Bevan, RAJ Byrne… - Acta Neuropathologica …, 2022 - Springer
Complement is involved in developmental synaptic pruning and pathological synapse loss
in Alzheimer's disease. It is posited that C1 binding initiates complement activation on …

Low‐molecular weight inhibitors of the alternative complement pathway

A Schubart, S Flohr, T Junt, J Eder - Immunological Reviews, 2023 - Wiley Online Library
Dysregulation of the alternative complement pathway predisposes individuals to a number
of diseases. It can either be evoked by genetic alterations in or by stabilizing antibodies to …

Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study

M Sloan, C Wincup, R Harwood, TA Pollak… - …, 2024 - academic.oup.com
Objective A limited range of neuropsychiatric symptoms have been reported in systemic
autoimmune rheumatic diseases (SARDs), with varied symptom prevalence. This study …

Exploring the potential of aptamers in targeting neuroinflammation and neurodegenerative disorders: Opportunities and challenges

AHY Kong, AJ Wu, OKY Ho, MMK Leung… - International Journal of …, 2023 - mdpi.com
Neuroinflammation is the precursor for several neurodegenerative diseases (NDDs), such
as Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS) …

Free complement and complement containing extracellular vesicles as potential biomarkers for neuroinflammatory and neurodegenerative disorders

M Burgelman, P Dujardin, C Vandendriessche… - Frontiers in …, 2023 - frontiersin.org
The complement system is implicated in a broad range of neuroinflammatory disorders such
as Alzheimer's disease (AD) and multiple sclerosis (MS). Consequently, measuring …

Complement‐targeted therapeutics: Are we there yet, or just getting started?

D Ricklin - European Journal of Immunology, 2024 - Wiley Online Library
Therapeutic interventions in the complement system, a key immune‐inflammatory mediator
and contributor to a broad range of clinical conditions, have long been considered important …

Brain-penetrant complement inhibition mitigates neurodegeneration in an Alzheimer's disease mouse model

WM Zelek, RJ Bevan, J Nimmo, M Dewilde… - Brain, 2024 - academic.oup.com
Complement activation is implicated in driving brain inflammation, self-cell damage and
progression of injury in Alzheimer's disease and other neurodegenerative diseases. Here …